Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 13Lymphoma, Large B-Cell, Diffuse 12Burkitt Lymphoma 12Lymphoma, Follicular 8Lymphoma, Non-Hodgkin 6Lymphoma 6Neoplasms 5Prostatic Neoplasms, Castration-Resistant 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Triple Negative Breast Neoplasms 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Neoplasms 1Macular dystrophy, corneal type 1 1Lymphadenopathy 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1

Interventions

venetoclax 5Rituximab 5Cyclophosphamide 4Whole-Body Irradiation 3Magnetic Resonance Spectroscopy 3Cyclosporine 3zanubrutinib 2pirtobrutinib 2fludarabine phosphate 2fludarabine 2Specimen Handling 2Prednisone 2Mycophenolic Acid 2Lenalidomide 2CT-P10 2Biopsy 2treosulfan 1pomalidomide 1obinutuzumab 1ibrutinib 1Vincristine 1Tacrolimus 1Stem Cell Transplantation 1Sirolimus 1R-CHOP protocol 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Methotrexate 1Melphalan 1Maintenance 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, B-Cell, Marginal Zone × Prednisone × 30 days × Clear all
NCT04542824 2026-06-02

EPCOREâ„¢ NHL-3

Genmab

Phase 1/2 Active not recruiting
78 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

NCT07609446 2026-05-27

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

The First Affiliated Hospital of Soochow University

Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡